rxstat › Shortages › Dextromethorphan Phenylephrine Pheniramine Guaifenesin

Dextromethorphan Phenylephrine Pheniramine Guaifenesin (Pulmorphan) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Dextromethorphan Phenylephrine Pheniramine Guaifenesin products are in shortage in Canada (1 of 1 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.

A combination cold medicine with a cough suppressant, a decongestant, an antihistamine and an expectorant.

Products affected

1 / 1

In shortage since

Apr 11, 2014

Reports on file

Talk to a pharmacist

Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.

Book a pharmacist appointment

Need your prescription switched?

If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.

See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

Shortage history (red bands = periods in shortage).

Reports by product

Active shortage

PULMORPHAN

10MG 3.75MG 7.5MG 50MG · SYRUP · LABORATOIRE RIVA INC

DIN 00513741 · since Apr 11, 2014, no end estimate · Disruption of the manufacture of the drug.

What's happening

Dextromethorphan Phenylephrine Pheniramine Guaifenesin is currently affected by an active shortage report filed with Health Canada by LABORATOIRE RIVA INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Dextromethorphan Phenylephrine Pheniramine Guaifenesin is classified under “COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS” (ATC R05FA).

Recent changes

No changes recorded yet.

Common questions

What is Dextromethorphan Phenylephrine Pheniramine Guaifenesin used for?

A combination cold medicine with a cough suppressant, a decongestant, an antihistamine and an expectorant.

When will Dextromethorphan Phenylephrine Pheniramine Guaifenesin be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Dextromethorphan Phenylephrine Pheniramine Guaifenesin in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (cough suppressants and expectorants, combinations)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Pseudoephedrine Guaifenesin Codeine (Cough) No current shortage Triprolidine Pseudoephedrine Codeine Guaifenesin No current shortage Dimetane Expectorant Dc (Brompheniramine Phenylephrine Hydrocodone Guaifenesin) Partial shortage 1 of 1 reported products affected Codeine Pheniramine Guaifenesin (Robitussin Ac) Partial shortage 1 of 2 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.